Basit öğe kaydını göster

The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study

dc.contributor.authorMeluzinova, Eva
dc.contributor.authorO'Neill, Gilmore N.
dc.contributor.authorERAKSOY, Mefküre
dc.contributor.authorRektor, Ivan
dc.contributor.authorDawson, Katherine
dc.contributor.authorKappos, Ludwig
dc.contributor.authorMiller, David
dc.contributor.authorMacManus, David
dc.contributor.authorGold, Ralf
dc.contributor.authorHavrdova, Eva
dc.contributor.authorLimmroth, Volker
dc.contributor.authorPolman, Chris
dc.contributor.authorSchmierer, Klaus
dc.contributor.authorYousry, Tarek
dc.contributor.authorYang, Minhua
dc.date.accessioned2022-02-18T09:54:22Z
dc.date.available2022-02-18T09:54:22Z
dc.identifier.citationKappos L., Miller D., MacManus D., Gold R., Havrdova E., Limmroth V., Polman C., Schmierer K., Yousry T., Yang M., et al., "The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study", 60th Annual Meeting of the American-Academy-of-Neurology, Illinois, Amerika Birleşik Devletleri, 12 - 19 Nisan 2008, cilt.70
dc.identifier.othervv_1032021
dc.identifier.otherav_69c8aaa5-8d09-4b90-b80c-4cd7fb2bca33
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178211
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectNeurology
dc.subjectNeurology (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.subjectTıp
dc.titleThe efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume70
dc.contributor.firstauthorID3375597


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster